Corcept Therapeutics Incorporated (CORT)
Debt-to-assets ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 621,517 | 594,022 | 524,625 | 617,848 | 583,430 | 533,255 | 496,364 | 468,123 | 423,756 | 585,399 | 568,480 | 552,398 | 571,731 | 534,125 | 497,823 | 445,494 | 412,312 | 367,022 | 328,679 | 320,212 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $621,517K
= 0.00
Based on the data provided for Corcept Therapeutics Inc, the debt-to-assets ratio has consistently been 0.00 for each quarter listed from Q1 2022 to Q4 2023. A debt-to-assets ratio of 0.00 indicates that the company has no debt in relation to its total assets during this period. This demonstrates that Corcept Therapeutics Inc has been operating with a debt-free capital structure, which can be viewed positively by investors and creditors as it signifies lower financial risk and potentially stronger financial health. It suggests that the company has been funding its operations and investments primarily through equity or retained earnings rather than debt financing. Utilizing this financing strategy may provide Corcept Therapeutics Inc with more financial flexibility and stability in the long run, as it has avoided the costs and risks associated with servicing debt.
Peer comparison
Dec 31, 2023